s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
S-3
Registration statement for specified transactions by certain issuers
Filed
Monday, August 14, 2023
Accession number
0001140361-23-039710
Documents
S-3
S-3
EXHIBIT 5.1
EX-5.1
EXHIBIT 23.1
EX-23.1
EXHIBIT 23.2
EX-23.2
FILING FEES TABLE
EX-FILING FEES
On sec.gov
Filing index
All files
Complete submission text
SGML header